KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Asset Writedowns and Impairment (2021 - 2023)

CareDx's Asset Writedowns and Impairment history spans 4 years, with the latest figure at -$2.3 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to -$2.3 million; the TTM value through Dec 2025 reached -$2.3 million, changed N/A, while the annual FY2022 figure was $840000.0, 65.53% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was -$2.3 million at CareDx, down from -$1.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $2.4 million in Q4 2021 and bottomed at -$2.3 million in Q4 2025.
  • The 4-year median for Asset Writedowns and Impairment is $840000.0 (2022), against an average of $203800.0.